---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-005682"
form_type: "8-K"
ticker: "ALBT"
cik: "0001630212"
company_name: "Avalon GloboCare Corp."
filed_at: "2026-01-20T23:59:59+00:00"
generated_at: "2026-05-16T09:33:16.382988+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Avalon GloboCare renews FDA registration for KetoAir; plans Q2 2026 launch via Catch-Up AI platform

## Summary
- FDA registration renewed for KetoAir breathalyzer (Reg. No. 3026284320) for ketogenic health management.
- Device measures breath acetone (BrAce) to provide real-time, non-invasive metabolic state insights.
- Planned B2B and B2C launch in Q2 2026 via Catch-Up, AI-powered short-form video SaaS platform.
- Compatible with iOS and Android smartphones; apps available on App Store and Google Play.

## SEC filing metadata
- accession: 0001213900-26-005682
- form_type: 8-K
- ticker: ALBT
- cik: 0001630212
- company_name: Avalon GloboCare Corp.
- filed_at: 2026-01-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630212/000121390026005682/0001213900-26-005682-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630212/000121390026005682/ea0273345-8k_avalon.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-005682
- JSON: https://secwatch.observer/filing/0001213900-26-005682.json
- Plain text: https://secwatch.observer/filing/0001213900-26-005682.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.